TEM
Tempus AI, Inc.
NASDAQ · USHealthcareMedical - Healthcare Information Services
$48.41-7.74%
Price as of Jul 20, 2026
TEM growth
Tempus AI, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +69.8%
- EBITDA
- +78.9%
- EBIT
- +65.0%
- EPS
- +62.8%
- Free cash flow
- -1.8%
- Operating cash flow
- +3.9%
Forward estimates
- Revenue
- +28.0%
- EBITDA
- —
- EPS
- +85.6%
Three-year CAGR
- Revenue
- +58.3%
- EBITDA
- +63.6%
- EBIT
- +65.5%
- Net income
- +65.3%
- EPS
- +69.3%
- Free cash flow
- -13.2%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.